A significant relationship between hormone receptor/HER2 status and TLG has been reported by Kaida et al. They observed that TLG was a promising biomarker to indicate clinicopathological features and tumor metabolism better than SUVmax or MTV (26). Here, ERBB2 is linked to neoplasm.